179 related articles for article (PubMed ID: 33184339)
1. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.
Urueña C; Sandoval TA; Lasso P; Tawil M; Barreto A; Torregrosa L; Fiorentino S
Sci Rep; 2020 Nov; 10(1):19639. PubMed ID: 33184339
[TBL] [Abstract][Full Text] [Related]
2. Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin.
Sandoval TA; Urueña CP; Llano M; Gómez-Cadena A; Hernández JF; Sequeda LG; Loaiza AE; Barreto A; Li S; Fiorentino S
Am J Chin Med; 2016; 44(8):1693-1717. PubMed ID: 27852125
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.
Urueña C; Gomez A; Sandoval T; Hernandez J; Li S; Barreto A; Fiorentino S
Integr Cancer Ther; 2015 Sep; 14(5):468-83. PubMed ID: 26220604
[TBL] [Abstract][Full Text] [Related]
4. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
[TBL] [Abstract][Full Text] [Related]
5. The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells.
Prieto K; Lozano MP; Urueña C; Alméciga-Díaz CJ; Fiorentino S; Barreto A
Apoptosis; 2020 Dec; 25(11-12):875-888. PubMed ID: 33156457
[TBL] [Abstract][Full Text] [Related]
6. Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.
Urueña C; Mancipe J; Hernandez J; Castañeda D; Pombo L; Gomez A; Asea A; Fiorentino S
BMC Complement Altern Med; 2013 Apr; 13():74. PubMed ID: 23552194
[TBL] [Abstract][Full Text] [Related]
7. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
[TBL] [Abstract][Full Text] [Related]
9. An Immunomodulatory Gallotanin-Rich Fraction From
Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
Front Immunol; 2020; 11():584959. PubMed ID: 33312174
[TBL] [Abstract][Full Text] [Related]
10. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.
Yousefnia S; Naseri D; Seyed Forootan F; Tabatabaeian M; Moattar F; Ghafghazi T; Nasr Esfahani MH; Ghaedi K
Clin Transl Oncol; 2020 Sep; 22(9):1619-1634. PubMed ID: 32056127
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
12. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and TRAIL enhance breast cancer stem cell death.
Yin S; Xu L; Bandyopadhyay S; Sethi S; Reddy KB
Int J Oncol; 2011 Oct; 39(4):891-8. PubMed ID: 21687939
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles.
Das S; Mukherjee P; Chatterjee R; Jamal Z; Chatterji U
Mol Cancer Ther; 2019 Mar; 18(3):680-692. PubMed ID: 30587555
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.
Zhou Q; Ye M; Lu Y; Zhang H; Chen Q; Huang S; Su S
PLoS One; 2015; 10(8):e0136694. PubMed ID: 26305906
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
Fernández-Nogueira P; Mancino M; Fuster G; López-Plana A; Jauregui P; Almendro V; Enreig E; Menéndez S; Rojo F; Noguera-Castells A; Bill A; Gaither LA; Serrano L; Recalde-Percaz L; Moragas N; Alonso R; Ametller E; Rovira A; Lluch A; Albanell J; Gascon P; Bragado P
Clin Cancer Res; 2020 Mar; 26(6):1432-1448. PubMed ID: 31699826
[TBL] [Abstract][Full Text] [Related]
17. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.
Ye S; Ding YF; Jia WH; Liu XL; Feng JY; Zhu Q; Cai SL; Yang YS; Lu QY; Huang XT; Yang JS; Jia SN; Ding GP; Wang YH; Zhou JJ; Chen YD; Yang WJ
Cancer Res; 2019 Sep; 79(18):4729-4743. PubMed ID: 31308046
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC).
Ballesteros-Ramírez R; Pinilla P; Sanchéz J; Torregrosa L; Aschner P; Urueña C; Fiorentino S
BMC Complement Med Ther; 2023 Sep; 23(1):309. PubMed ID: 37670337
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
Dandawate PR; Subramaniam D; Jensen RA; Anant S
Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
[TBL] [Abstract][Full Text] [Related]
20. ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy.
Dutta I; Dieters-Castator D; Papatzimas JW; Medina A; Schueler J; Derksen DJ; Lajoie G; Postovit LM; Siegers GM
Cancer Lett; 2021 Jan; 496():156-168. PubMed ID: 33045304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]